Results 241 to 250 of about 50,045 (313)

The genetic analysis of eight families with hemophilia B in Mongolia: Identification of two novel mutation. [PDF]

Mol Genet Genomic Med
Munkhuu P, Bazarragchaa M, Ichinkhorloo P, Yoo KY, Ayush EA, Batjargal O, Namjil E, Jav S, Purevdorj E, Lkhagvasuren S.   +9 more
europepmc   +1 more source

Clinical data on treatment regimen and use of medication among patients with hemophilia B in Korea. [PDF]

Blood Res
Park YS, Park JK, Park JA, Baek HJ, Lee JH, You CW, Lyu CJ, Choi EJ.   +7 more
europepmc   +1 more source

RESPONSIVENESS OF HEMOPHILIA B-CAUSING NONSENSE MUTATIONS TO RIBOSOME READTHROUGH-INDUCING DRUGS STRICTLY DEPENDS ON THE NUCLEOTIDE AND PROTEIN CONTEXT

, 2016
Alessio Branchini, Mattia Ferrarese, Silvia Lombardi, Marcello Baroni, Matteo Campioni, Francesco Burini, Francesco Bernardi, Mirko Pinotti   +7 more
openalex   +1 more source

Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec. [PDF]

Blood Adv
Anguela XM, High KA.
europepmc   +1 more source

A transposable element prevents severe hemophilia B and provides insights into the evolution of new- and old world primates. [PDF]

PLoS One
Kopp J, Rovai A, Ott M, Wedemeyer H, Tiede A, Böhmer HJ, Marques T, Langemeier J, Bohne J, Krooss SA.   +9 more
europepmc   +1 more source

Blood coagulation factor IX: structural insights impacting hemophilia B therapy.

Blood
Bos MHA, van Diest RE, Monroe DM.
europepmc   +1 more source

Protein S antibody as an adjunct therapy for hemophilia B. [PDF]

Blood Adv
Wilson HP, Pierre A, Paysse AL, Kumar N, Cooley BC, Rudra P, Dorsey AW, Polania-Villanueva D, Chatterjee S, Janbain M, Velez MC, Majumder R.   +11 more
europepmc   +1 more source

Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B. [PDF]

Sci Rep
Vandewalle B, Castaman G, Álvarez-Román MT, Ettingshausen CE, Nemes L, Tomic R, Martins P, Rodrigues JF, Pinachyan K.   +8 more
europepmc   +1 more source

Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.

Blood
Lee K, Chau JQ, Suber YB, Sternberg AR, Pishko AM, George LA, Bhoj VG, Doshi BS, Samelson-Jones BJ.   +8 more
europepmc   +1 more source

[Genetic forms of hemophilia B: two Polish families with hemophilia B+].

Acta haematologica Polonica, 1973
openaire   +1 more source